Skip to content

Reading and Stuttering

Reading Problems and Stuttering

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06836115
Enrollment
200
Registered
2025-02-20
Start date
2025-02-25
Completion date
2025-05-01
Last updated
2025-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dyslexia

Brief summary

Dyslexia is a common neurodevelopmental condition, which manifests itself in the form of reading difficulties and occurs in 7-10% of the population (Peterson & Pennington, 2012). As for dyslexia, it is one of the most common learning disorders and the most common cause of difficulties with reading, writing, and spelling. The global prevalence of dyslexia is estimated to be between 5% and 10% of the population, but it may be as high as 17% (Sprenger-Charolles et al., 2011). Stuttering is a speech disorder characterized by involuntary, audible, or silent repetitions or prolongations of sounds or syllables, along with disturbances in the fluency of verbal phrases.Stuttering and dyslexia are two processing deficits that have an impact on a person's social and academic lives, especially as they usually affect the pediatric population more than adults. Even though they affect different domains, they have similar characteristics in their pathogenesis, epidemiology, and impact on life (Algaidy et al., 2023). The aim of the study will be to identify the prevelance of dyslexia in developmental stuttering.

Interventions

None listed

Sponsors

Wafaa Helmy Abdelhakeem
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
9 Years to 10 Years
Healthy volunteers
Yes

Inclusion criteria

* children with stuttering

Exclusion criteria

* children with delayed language development

Design outcomes

Primary

MeasureTime frameDescription
4- Arabic Reading Testbaselinearabic reading test in scores

Contacts

Primary ContactWafaa Helmy Abd El-hakeem
wafaa.helmy@edu.mu.eg01091813874

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026